Chuangye Software, DiAn Diagnostics, and TongCe Medical Announce Filing of Prospectus for RMB 10B Initial Close of Zhejiang Health Industry Equity Investment Fund
Recently, B-Soft announced in a public filing that the companyJoint Dian Diagnostics and Topchoice Medical Plan to Participate in the Initiative Led by Dian DiagnosticsJointly initiated and established by nine parties, including Mr. Chen Haibin, the actual controller; Mr. Lv Jianming, the actual controller of Topchoice Medical; and Mr. Ge Hang, the actual controller of B-Soft.Zhejiang Grand Health Industry Fund, and signedLetter of Intent for Cooperation Framework Agreement.
It is reported that the general partner (GP) of the healthcare fund is structured as a limited partnership, with a fund size of RMB 10 million. The specific composition is as follows:
The general partner contributes RMB 1 million. This general partner is structured as a limited liability company with a registered capital of RMB 1 million. Among this, Dian Holdings contributes RMB 500,000, and Haijun Technology contributes RMB 300,000.RMB, Zhongyu Technology contributed RMB 100,000, and the GP management team of the Big Health Fund contributed RMB 100,000.
The limited partners contributed a total of RMB 9 million. Specifically, Chen Haibin contributed RMB 4.5 million, Lv Jianming contributed RMB 2.7 million, Ge Hang contributed RMB 900,000, and the GP management team of the Big Health FundCapital contribution of RMB 900,000.
Fund Name: Zhejiang Grand Health Industry Equity Investment Fund (Limited Partnership) (subject to final industrial and commercial registration).
Fund Duration: 5+2 Years
Fund Type: Limited Partnership Private Equity Fund
Fund Type: RMB Fund
Initial Fund Size: RMB 1 billion
Total Scale of the Future Fund: RMB 10 billion
Proposed Capital Contribution Structure for the Initial Fund: Dian Diagnostics, Topchoice Medical, and B-Soft, as cornerstone investors of the fund, have committed to contribute RMB 150 million, RMB 100 million, and RMB 50 million respectively, totaling RMB 300 million. The General Partner shall subscribe for a 1% interest. In the event that government guidance funds participate, their aggregate contribution shall not exceed 20% of the total fund size. The remaining capital shall be raised from other social investors.
Investment Focus: Based in core markets, focused on niche sectors, and integrating global resources. Key investments in medicalhealthcare services, precision medicine, and smart healthcare subsectors, forming a high-value-added closed-loop value chain to build medical healthHealth Ecosystem.
Investment Strategy: Focusing on controlling acquisitions, growth-stage investments, and incubation-stage projects, fully leveraging the initiatingLeveraging human capital in industrial operation and management capabilities to seize opportunities that general funds often miss, thereby enhancing the value of portfolio companies and projects and maximizing returns for fund investors.
This participation in the establishment of the Big Health Fund represents a strategic exploration by B-Soft for long-term development. Through cooperation with leading listed companies in Zhejiang Province’s big health industry, it can effectively integrate multi-party advantageous resources.Integration creates synergies, thereby helping to reduce decision-making and financial risks associated with the Company’s early-stage investments and enhancing the overall quality of its investment portfolio. For the Company’s long-term development strategy...will have a positive impact.